Search Results for "Exparel"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Exparel. Results 1 to 2 of 2 total matches.
See also: bupivacaine

Bupivacaine Liposome Injection (Exparel) for Postsurgical Pain

   
The Medical Letter on Drugs and Therapeutics • Apr 02, 2012  (Issue 1387)
Bupivacaine Liposome Injection (Exparel) for Postsurgical Pain ...
The FDA has approved a new formulation (Exparel – Pacira) of the local anesthetic bupivacaine (Marcaine, and others) for use in the management of postsurgical pain in adults.
Med Lett Drugs Ther. 2012 Apr 2;54(1387):26-7 |  Show IntroductionHide Introduction

Bupivacaine/Meloxicam (Zynrelef) for Postsurgical Pain

   
The Medical Letter on Drugs and Therapeutics • Jan 24, 2022  (Issue 1642)
(Exparel) is a sustainedrelease injectable formulation that is FDA-approved to provide postsurgical local ...
The FDA has approved a fixed-dose combination of the amide local anesthetic bupivacaine and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam as an extended-release (ER) solution (Zynrelef – Heron) for single-dose, intraoperative, soft-tissue or periarticular instillation to provide postsurgical analgesia for up to 72 hours in adults undergoing foot and ankle, small-to-medium open abdominal, or lower extremity total joint arthroplasty surgical procedures.
Med Lett Drugs Ther. 2022 Jan 24;64(1642):13-5 |  Show IntroductionHide Introduction